4
Changes in Ownership
Atea Pharmaceuticals, Inc. Filed Acc 0000950170-24-010972
President, CEO, and Chairman sold 56,910 shares at $3.85 ($218,819)
- President, CEO, and Chairman acquired 173,467 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sommadossi Jean-Pierre President, CEO, and Chairman | 2024-01-31 | Option exercise 10b5-1 | +173,467 | 173,467 | D | ||
| Sommadossi Jean-Pierre President, CEO, and Chairman | 2024-02-01 | Sale 10b5-1 | −56,910 | $3.85 | $218,819 | 116,557 | D |
| Derivatives | |||||||
| Sommadossi Jean-Pierre President, CEO, and Chairman | 2024-01-31 | Option exercise · Restricted Stock Units 10b5-1 | −173,467 | 346,933 | D | ||
| Sommadossi Jean-Pierre President, CEO, and Chairman | 2024-01-31 | Grant or award · Stock Option (Right to Buy) 10b5-1 | +448,000 | 448,000 | D | ||
| Open-market sales · 56,910 sh · avg $3.85 · $218,819 | |||||||
Loading xslF345X05/ownership.xml…